AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
Zapisane w:
| 1. autor: | |
|---|---|
| Korporacja: | |
| Format: | Książka |
| Język: | angielski |
| Wydane: |
Dhaka :
BME DEPT. MIST,
c2026.
|
| Hasła przedmiotowe: | |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy: AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
- IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
- IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
- Inside the FDA : the business and politics behind the drugs we take and the food we eat /
- AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
- AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
- ART AGAINST GENOCIDE /